Recent Coverage

 

June 9, 2017

The Huffington Post
Pioneer in Both Biotech & Business Left Noteworthy Legacy
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler, click here. (06/09/17) Read full article

June 8, 2017

Smarter Analyst
Exclusive Interview with RepliCel Life Sciences President and CEO Lee Buckler
To read the full article as it appears on SmarterAnalyst.com by Julie Lamb, click here. (06/08/17) Read full article

June 6, 2017

The Huffingtonpost
Promise of Regenerative Medicine Already Upon Us
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler, click here. (06/06/17) Read full article

May 30, 2017

Cantech Letter
RepliCel Life Sciences gets price target raise at Echelon Wealth Partners
To read the full article as it appears on Cantech Letters by Nick Waddell, click here. (3/30/17) Read full article

May 17, 2017

Cosmetics Design-asia
Cell therapy: Scientific breakthrough treats signs of ageing
To read the full article as it appears on Cosmetics design-asia.com by Natasha Spencer, click here. (5/17/17) Read full article

May 14, 2017

Metro News
RepliCel, cell therapy companies ready to give you athletic immortality
To read the full article as it appears on Metro News by Matt Burke, click here. (5/14/17) Read full article

April 22, 2017

Medical Research
RepliCel Developing Autologous Cell Therapies For Skin, Hair and Tendon Regeneration
To read the full interview as it appears on MedicalResearch.com, click here. (4/22/17) Read full article

April 12, 2017

The Life Sciences Report
String of Positive Trial Results Boosts RepliCel’s Profile
To read the full article as it appears on thelifesciencesreport.com, click here. (04/12/17) Read full article

April 10, 2017

Future Tech Podcast
RepliCel – Stem Cell Therapies Using Your Own Cells
To listen to Podcast and View Transcript on Future Tech Podcast, click here Read full article

April 7, 2017

Clinical Trials
Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)
To read the full study as it appears on ClinicalTrials.gov, click here.  Source: Clinical Trials. gov (4/7/17) Read full article